CLXT - Calyxt, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
11.45
-0.67 (-5.53%)
At close: 4:00PM EST

11.45 0.00 (0.00%)
After hours: 4:44PM EST

Stock chart is not supported by your current browser
Previous Close12.12
Open12.25
Bid11.34 x 800
Ask17.00 x 800
Day's Range11.25 - 12.25
52 Week Range11.25 - 27.23
Volume55,848
Avg. Volume61,785
Market Cap370.366M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.14
Earnings DateNov 14, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.05
Trade prices are not sourced from all markets
  • Business Wire7 days ago

    Calyxt to Hold Third Quarter 2018 Investor Conference Call on Wednesday, November 14, at 8 a.m. EST – 7 a.m. CST

    Calyxt, Inc. , a consumer-centric, food- and agriculture-focused company, today announced the company will report financial results for the third quarter of 2018 on Tuesday, November 13, after the close of regular stock market trading hours.

  • Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know
    Zacks7 days ago

    Will Calyxt (CLXT) Report Negative Earnings Next Week? What You Should Know

    Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire28 days ago

    Calyxt Hires Former Cargill Supply Chain Manager

    Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused Company, announced today that Aaron Snyder has joined the Calyxt team as a supply chain manager, effective October 15, 2018. Mr. Snyder will be responsible for procuring all materials that are needed for production, as well as overseeing shipping operations, implementing and managing new planning processes. “Aaron’s impressive record in managing logistics operations and supply chain strategy makes him the perfect choice to manage our operations here at Calyxt,” said Jim Blome, CEO of Calyxt.

  • Business Wirelast month

    Calyxt Harvests High-Fiber Wheat Field Trials

    Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company has completed the inaugural harvest of its high-fiber wheat product, the world’s first gene-edited, consumer-focused wheat product. The high-fiber wheat product is already the seventh Calyxt product that has been deemed non-regulated by the U.S. Department of Agriculture (USDA), including powdery mildew-resistant wheat, high-oleic soybeans, high-oleic / low-linoleic soybeans, improved quality alfalfa, cold storable potatoes and reduced browning potatoes. “The completion of these field trials for our high-fiber wheat is an important milestone as we continue to advance toward the finish line in commercializing our first-ever gene-edited wheat product for consumers,” said Jim Blome, CEO of Calyxt.

  • GlobeNewswirelast month

    Consolidated Research: 2018 Summary Expectations for LaSalle Hotel Properties, EchoStar, Clean Energy Fuels, Innophos, Data I/O, and Calyxt — Fundamental Analysis, Key Performance Indications

    NEW YORK, Oct. 09, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • Business Wirelast month

    Calyxt Inks Agreement with KemX Global to Refine High-Oleic Soybean Oil

    Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, announced today that the Company has inked an agreement with KemX Global, a leading provider of innovative organic processing of oils, to refine Calyxt’s high-oleic soybean oil – an advancement that will allow Calyxt to produce food-grade high-oleic soybean oil as the Company’s first product that is expected to hit the market in late 2018/ early 2019. “This agreement is another important step in scaling up Calyxt’s supply chain, leading up to the commercialization of our high-oleic soybean oil,” said Manoj Sahoo, Calyxt’s Chief Commercial Officer. “KemX’s Boone Plant, which has a strong reputation and Level 2 certification from the Safe Quality Food Institute, permits Calyxt to work with multiple crush plants in the Midwest region.

  • Business Wire2 months ago

    Calyxt Signs Agreement with American Natural Processors to Crush and Process its High-Oleic Soybeans

    Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused Company, announced today an agreement with American Natural Processors (ANP), a leading provider of innovative non-GMO and organic processing of oils, flours and meals, to crush Calyxt’s high-oleic soybean variety, and produce the Company’s high oleic soybean oil, its first product expected to hit the market in late 2018 / early 2019. “With this collaboration, Calyxt has taken an important step toward the commercialization of our high-oleic soybean oil by contracting with a processor with a strong track record of food quality and safety, and that is committed to the non-gmo and organic industries,” said Manoj Sahoo, Calyxt Chief Commercial Officer.

  • Business Wire2 months ago

    Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

    Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to foster the development of the Company’s consumer-focused products, including the upcoming commercial launch of Calyxt’s first product, high-oleic soybean oil. Jim Blome is a high-impact, global leader with over 25 years of leadership experience in the agriculture industry, building teams and strategies with consumer-focused cultures to better meet consumer needs and maximize market share growth.

  • Business Wire2 months ago

    Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

    Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ:CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to foster the development of the Company’s consumer-focused products, including the upcoming commercial launch of Calyxt’s first product, high-oleic soybean oil. Jim Blome is a high-impact, global leader with over 25 years of leadership experience in the agriculture industry, building teams and strategies with consumer-focused cultures to better meet consumer needs and maximize market share growth.

  • Business Wire2 months ago

    Christopher J. Neugent, a Leader of the Food Industry, Joins Calyxt Board of Directors

    Calyxt, Inc. (CLXT) announced today that Christopher J. Neugent, Executive Vice President of Strategy of Post Holdings, Inc. (POST), joined its board of directors. Mr. Neugent has nearly three decades of experience in the consumer packaged goods and food industries, including as President and CEO of Post Consumer Brands and as Chairman and CEO of MOM Brands, which was purchased by Post Holdings in 2015. “Mr. Neugent’s industry expertise and executive leadership will be invaluable to Calyxt during a pivotal time in our growth as we are heading to our first commercial launch of a product to market, our high oleic soybean oil” said Dr. André Choulika, Chairman of Calyxt’s Board of Directors.

  • Business Wire3 months ago

    Calyxt to Present at Wells Fargo Securities Agribusiness Panel

    Johnston, IA, Monday, August 27, 2018

  • Business Wire3 months ago

    Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO

    Calyxt, Inc. (CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today its Board of Directors has appointed Yves Ribeill, Ph.D., as Interim Chief Executive Officer, effective immediately. Dr. Ribeill replaces Federico Tripodi, who is leaving the Company to pursue other opportunities. Currently a member of Calyxt’s Board of Directors, Dr. Ribeill will work closely with the executive management team to promote the development of the Company’s products to benefit consumers, including the commercial launch of Calyxt’s high-oleic soybean oil.

  • Reuters3 months ago

    Gene-editing startups ignite the next 'Frankenfood' fight

    Calyxt Inc, an eight-year-old firm co-founded by a genetics professor, altered the genes of a soybean plant to produce healthier oil using the cutting-edge editing technique rather than conventional genetic modification. Seventy-eight farmers planted those soybeans this spring across 17,000 acres in South Dakota and Minnesota, a crop expected to be the first gene-edited crop to sell commercially, beating out Fortune 500 companies. Seed development giants such as Monsanto, Syngenta AG and DowDuPont Inc have dominated genetically modified crop technology that emerged in the 1990s.

  • Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates
    Zacks3 months ago

    Calyxt (CLXT) Reports Q2 Loss, Tops Revenue Estimates

    Calyxt (CLXT) delivered earnings and revenue surprises of 7.41% and 96.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press3 months ago

    Calyxt: 2Q Earnings Snapshot

    The New Brighton, Minnesota-based company said it had a loss of 25 cents per share. The genetically modified food company posted revenue of $196,000 in the period. Calyxt shares have decreased 20 percent ...

  • Business Wire3 months ago

    Calyxt Reports Financial Results for Second Quarter and Half-Year 2018

    As of June 30th, successfully contracted over 17,000 high-oleic / no trans-fat soybean acres with 78 growers.

  • Reuters4 months ago

    Battle lines drawn as EU court weighs fate of gene-edited crops

    Gene editing in agriculture takes centre stage next Wednesday when Europe's highest court rules in a case that could determine the fate of the technology that is already making waves in the field of medicine. The European Union has long restricted the use of genetically modified organisms (GMOs) widely adopted around the world, but there is legal uncertainty as to whether modern gene editing of crops should fall under the same strict GMO rules. The European Court of Justice (ECJ) will rule whether the use of genetic mutation, or mutagenesis, which is now exempt from GMO rules, should differentiate between techniques that have been used for decades and the new gene-editing technology.

  • Business Wire4 months ago

    Calyxt and S&W Seed Company Announce Milestone in Alfalfa Seed Development Program

    Calyxt, Inc. (CLXT), a consumer-centric, food- and agriculture-focused company, and S&W Seed Company (SANW), a global leader in the alfalfa seed industry, today announced the successful transfer of their proprietary alfalfa seed and plants from the research and development facility at Calyxt to S&W for field evaluation and testing. In 2015, Calyxt and S&W Seed Company embarked on a collaboration to research, develop, produce and commercialize alfalfa seed products involving Calyxt’s proprietary gene editing technology, TALEN®, and S&W’s industry-leading alfalfa seed genetics. The collaboration between Calyxt and S&W is focused on providing enhanced traits in alfalfa that can drive improved productivity, while decreasing input costs to meet the growing global demand for improved quality alfalfa seeds.

  • Zacks Industry Outlook Highlights: Archer Daniels Midland, Calyxt and Adecoagro
    Zacks4 months ago

    Zacks Industry Outlook Highlights: Archer Daniels Midland, Calyxt and Adecoagro

    Zacks Industry Outlook Highlights: Archer Daniels Midland, Calyxt and Adecoagro

  • Calyxt Sees Hammer Chart Pattern: Time to Buy?
    Zacks4 months ago

    Calyxt Sees Hammer Chart Pattern: Time to Buy?

    Calyxt Sees Hammer Chart Pattern: Time to Buy?

  • Business Wire6 months ago

    Calyxt Announces Successful Closing of $60.9 Million Public Offering

    Cellectis S.A. and Calyxt, Inc. today announced the closing of Calyxt’s follow-on public offering of 4,057,500 shares of Calyxt’s common stock at a public offering price of $15.00 per share.